{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:15:35Z","timestamp":1793049335978,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jcf.2024.01.012","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:31:10Z","timestamp":1708561870000},"page":"388-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4070-1023","authenticated-orcid":false,"given":"E","family":"De Wachter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"De Boeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Sermet-Gaudelus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1705-4780","authenticated-orcid":false,"given":"NJ","family":"Simmonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2331-278X","authenticated-orcid":false,"given":"A","family":"Munck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Naehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Barben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SJ","family":"Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0580-2478","authenticated-orcid":false,"given":"SB","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1532-1486","authenticated-orcid":false,"given":"I","family":"Fajac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PM","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Girodon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Gonska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WW","family":"Grody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1534-5629","authenticated-orcid":false,"given":"M","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3505-6691","authenticated-orcid":false,"given":"A","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4635-386X","authenticated-orcid":false,"given":"E","family":"Kerem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KS","family":"Raraigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2222-4238","authenticated-orcid":false,"given":"S","family":"van Koningsbruggen-Rietschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4954-8339","authenticated-orcid":false,"given":"MD","family":"Waller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6516-9083","authenticated-orcid":false,"given":"KW","family":"Southern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jcf.2024.01.012_bib0001","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jcf.2022.09.011","article-title":"ECFS standards of care on CFTR-related disorders: updated diagnostic criteria","volume":"21","author":"Castellani","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2024.01.012_bib0002","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jcf.2022.09.005","article-title":"ECFS standards of care on CFTR-related disorders: diagnostic criteria of CFTR dysfunction","volume":"21","author":"Sermet-Gaudelus","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"9","key":"10.1016\/j.jcf.2024.01.012_bib0003","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.3390\/ijerph15092020","article-title":"Cystic fibrosis mortality in childhood. Data from European cystic fibrosis society patient registry","volume":"15","author":"Zolin","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jcf.2024.01.012_bib0004","unstructured":"Cystic Fibrosis Foundation Patient Registry; 2021 Annual data report Bethesda, Maryland \u00a92022 Cystic Fibrosis Foundation."},{"key":"10.1016\/j.jcf.2024.01.012_bib0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/ijns6010018","article-title":"Newborn screening for CF across the globe- where is it worthwhile?","volume":"6","author":"Scotet","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jcf.2024.01.012_bib0006","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/apa.15155","article-title":"Cystic fibrosis in the year 2020: a disease with a new face","volume":"109","author":"De Boeck","year":"2020","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jcf.2024.01.012_bib0007","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2024.01.012_bib0008","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jpeds.2009.09.001","article-title":"Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis","volume":"155","author":"Borowitz","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2024.01.012_bib0009","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jcf.2015.01.001","article-title":"Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): a new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening","volume":"14","author":"Munck","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.012_bib0010","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcf.2020.11.006","article-title":"Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome\/cystic fibrosis screen positive, inconclusive diagnosis (CRMS\/CFSPID)","volume":"20","author":"Barben","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.012_bib0011","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1378\/chest.11-2543","article-title":"Role of cystic fibrosis transmembrane conductance regulator in patients with chronic sinopulmonary disease","volume":"142","author":"Gonska","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2024.01.012_bib0012","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jcf.2012.05.001","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis","volume":"11","author":"Ooi","year":"2012","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.012_bib0013","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1164\/rccm.200509-1377OC","article-title":"Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials","volume":"174","author":"Wilschanski","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2024.01.012_bib0014","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00439-005-0059-z","article-title":"The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis","volume":"118","author":"Bishop","year":"2005","journal-title":"Hum Genet"},{"key":"10.1016\/j.jcf.2024.01.012_bib0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcf.2018.09.002","article-title":"Phenotypic spectrum of patients with cystic fibrosis and cystic fibrosis-related disease carrying p.Arg117His","volume":"18","author":"Keenan","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.012_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155624","article-title":"Benign and deleterious cystic fibrosis transmembrane conductance regulator mutations identified by sequencing in positive cystic fibrosis newborn screen children from California","volume":"11","author":"Salinas","year":"2016","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.jcf.2024.01.012_bib0017","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1542\/peds.97.4.524","article-title":"Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis","volume":"97","author":"Farrell","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2024.01.012_bib0018","doi-asserted-by":"crossref","first-page":"e1377","DOI":"10.1542\/peds.2014-2081","article-title":"Inconclusive diagnosis of cystic fibrosis after newborn screening","volume":"135","author":"Ooi","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2024.01.012_bib0019","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1152\/physiol.00041.2006","article-title":"Cystic fibrosis: lessons from the sweat gland","volume":"22","author":"Quinton","year":"2007","journal-title":"Physiology"},{"key":"10.1016\/j.jcf.2024.01.012_bib0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0140-6736(91)93377-L","article-title":"Abnormal frequency of delta F508 mutation in neonatal transitory hypertrypsinaemia","volume":"337","author":"Laroche","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2024.01.012_bib0021","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ajmg.a.30470","article-title":"Cystic fibrosis carriers have higher neonatal immunoreactive trypsinogen values than non-carriers","volume":"135","author":"Castellani","year":"2005","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jcf.2024.01.012_bib0022","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1073\/pnas.1914912117","article-title":"Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions","volume":"117","author":"Miller","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcf.2024.01.012_bib0023","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ymgme.2021.08.008","article-title":"Challenging the dogma of the healthy heterozygote: implications for newborn screening policies and practices","volume":"134","author":"Farrell","year":"2021","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jcf.2024.01.012_bib0024","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3390\/diagnostics10080570","article-title":"Cystic fibrosis-screening positive inconclusive diagnosis: newborn screening and long-term follow-up permits to early identify patients with CFTR-related disorders","volume":"10","author":"Castaldo","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.jcf.2024.01.012_bib0025","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ppul.24634","article-title":"Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening","volume":"55","author":"Munck","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.01.012_bib0026","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jcf.2015.03.006","article-title":"Benign outcome among positive cystic fibrosis newborn screen children with non-CF-causing variants","volume":"14","author":"Salinas","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.012_bib0027","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-051740","article-title":"Outcomes of cystic fibrosis screening-positive infants with inconclusive diagnosis at school age","volume":"148","author":"Gonska","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2024.01.012_bib0028","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jcf.2022.08.007","article-title":"Impact of antibiotic eradication therapy of Pseudomonas aeruginosa on long term lung function in cystic fibrosis","volume":"22","author":"Gascon Casaredi","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.012_bib0029","doi-asserted-by":"crossref","first-page":"17421","DOI":"10.1038\/s41598-020-74502-1","article-title":"Lung function over the life course of paediatric and adult patients with cystic fibrosis from a large multi-centre registry","volume":"10","author":"Earnest","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcf.2024.01.012_bib0030","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcf.2016.07.012","article-title":"Reduced survival in adult cystic fibrosis despite attenuated lung function decline","volume":"16","author":"Keating","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.012_bib0031","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.gim.2021.08.012","article-title":"Accurate assignment of disease liability to genetic variants using only population data","volume":"24","author":"Collaco","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/j.jcf.2024.01.012_bib0032","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3390\/diagnostics10121080","article-title":"CRMS\/CFSPID subjects carrying D1152H CFTR variant: can the second variant be a predictor of disease development?","volume":"10","author":"Terlizzi","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jcf.2024.01.012_bib0033","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1002\/ppul.25683","article-title":"Outcomes of early repeat sweat testing in infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome\/CF screen-positive, inconclusive diagnosis","volume":"56","author":"Terlizzi","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2024.01.012_bib0034","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jcf.2021.03.015","article-title":"A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS\/CFSPID) in six Italian centres","volume":"20","author":"Terlizzi","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"Suppl 2","key":"10.1016\/j.jcf.2024.01.012_bib0035","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S1569-1993(11)60014-3","article-title":"Recommendations for the classification of diseases as CFTR-related disorders","volume":"10","author":"Bombieri","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.012_bib0036","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/ijns6020025","article-title":"Processing Newborn Bloodspot Screening Results for CF","volume":"6","author":"Barben","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jcf.2024.01.012_bib0037","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jcf.2019.04.004","article-title":"International approaches for delivery of positive newborn bloodspot screening results for CF","volume":"18","author":"Chudleigh","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.012_bib0038","article-title":"Qualitative exploration of health professionals' experiences of communicating positive newborn bloodspot screening results for nine conditions in England","volume":"10","author":"Chudleigh","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jcf.2024.01.012_bib0039","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/ijns5020023","article-title":"Psychological Impact on Parents of an Inconclusive Diagnosis Following Newborn Bloodspot Screening for Cystic Fibrosis: a Qualitative Study","volume":"5","author":"Johnson","year":"2019","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jcf.2024.01.012_bib0040","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/j.1651-2227.2009.01485.x","article-title":"Inconclusive cystic fibrosis neonatal screening results: long-term psychosocial effects on parents","volume":"98","author":"Perobelli","year":"2009","journal-title":"Acta Paediatr"},{"issue":"10","key":"10.1016\/j.jcf.2024.01.012_bib0041","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ng.2745","article-title":"Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene","volume":"45","author":"Sosnay","year":"2013","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.jcf.2024.01.012_bib0042","doi-asserted-by":"crossref","DOI":"10.1002\/humu.23276","article-title":"CFTR-France, a national relational patient database for sharing genetic and phenotypic data associated with rare CFTR variants","volume":"38","author":"Claustres","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jcf.2024.01.012_bib0043","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1164\/rccm.201901-0145OC","article-title":"Correlating cystic fibrosis transmembrane conductance regulator function with clinical features to inform precision treatment of cystic fibrosis","volume":"199","author":"McCague","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcf.2024.01.012_bib0044","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40246-022-00407-x","article-title":"Expanding ACMG variant classification guidelines into a general framework","volume":"16","author":"Masson","year":"2022","journal-title":"Hum Genomics"},{"issue":"5","key":"10.1016\/j.jcf.2024.01.012_bib0045","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.21037\/jtd.2018.04.134","article-title":"Next-generation sequencing for identifying genetic mutations in adults with bronchiectasis","volume":"10","author":"Guan","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jcf.2024.01.012_bib0046","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00439-020-02122-w","article-title":"Genetics of the congenital absence of the vas deferens","volume":"140","author":"Bieth","year":"2021","journal-title":"Hum Genet"},{"issue":"9920","key":"10.1016\/j.jcf.2024.01.012_bib0047","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(13)61092-2","article-title":"Carrier screening for cystic fibrosis in the new era of medications that restore CFTR function","volume":"383","author":"Massie","year":"2014","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.jcf.2024.01.012_bib0048","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1001\/jama.2022.17197","article-title":"The challenge of emergency abortion care following the dobbs ruling","volume":"328","author":"MacDonald","year":"2022","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jcf.2024.01.012_bib0049","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/AOG.0000000000004928","article-title":"Roe v wade and the threat to fertility care","volume":"140","author":"Feinberg","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.jcf.2024.01.012_bib0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: the 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2024.01.012_bib0051","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jcf.2016.07.001","article-title":"ERS\/ECFS task force: the provision of care for adults with cystic fibrosis in Europe. Limitations to providing adult cystic fibrosis care in Europe: results of a care centre survey","volume":"16","author":"Madge","year":"2017","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2024.01.012_bib0052","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jcf.2018.04.003","article-title":"Insights into the cystic fibrosis care in Eastern Europe: results of survey","volume":"17","author":"Walicka-Serzysko","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.012_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-1993(21)01743-4","article-title":"Do fertility clinics use the current recommendations to exclude CF in men with congenital bilateral absence of the vas deferens? A pilot study","author":"Destoop","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2024.01.012_bib0054","doi-asserted-by":"crossref","first-page":"00227","DOI":"10.1183\/23120541.00227-2022","article-title":"Diagnostic agreement among experts assessing adults presenting with possible cystic fibrosis: need for improvement and implications for patient care","volume":"8","author":"Franciosi","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jcf.2024.01.012_bib0055","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2024.01.012_bib0056","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jcf.2014.09.005","article-title":"Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation","volume":"13","author":"De Boeck","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.01.012_bib0057","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2024.01.012_bib0058","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2024.01.012_bib0059","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.21037\/tau.2020.04.05","article-title":"Genetics of CFTR and male infertility","volume":"10","author":"Bieniek","year":"2021","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.jcf.2024.01.012_bib0060","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1055\/s-0039-1696664","article-title":"Treating the underlying cystic fibrosis transmembrane conductance regulator defect in patients with cystic fibrosis","volume":"40","author":"Cuyx","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcf.2024.01.012_bib0061","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02379-2018","article-title":"Intestinal organoids to model cystic fibrosis","volume":"54","author":"van Mourik","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2024.01.012_bib0062","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3389\/fped.2020.00536","article-title":"Functional profiling of CFTR-directed therapeutics using pediatric patient-derived nasal epithelial cell models","volume":"8","author":"Park","year":"2020","journal-title":"Front Pediatr"},{"issue":"6","key":"10.1016\/j.jcf.2024.01.012_bib0063","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s43441-021-00315-7","article-title":"Practical considerations and recommendations for master protocol framework: basket, umbrella and platform trials","volume":"55","author":"Lu","year":"2021","journal-title":"Ther Innov Regul Sci"},{"issue":"7549","key":"10.1016\/j.jcf.2024.01.012_bib0064","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/520609a","article-title":"Personalized medicine: time for one-person trials","volume":"520","author":"Schork","year":"2015","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jcf.2024.01.012_bib0065","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00405-012-2124-2","article-title":"Smell in cystic fibrosis","volume":"270","author":"Lindig","year":"2013","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jcf.2024.01.012_bib0066","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/all.12778","article-title":"Measurements of nasal airflow and patency: a critical review with emphasis on the use of peak nasal inspiratory flow in daily practice","volume":"71","author":"Ottaviano","year":"2016","journal-title":"Allergy"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324000110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324000110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:30:43Z","timestamp":1777649443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199324000110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1569199324000110"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2024.01.012","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2024.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}